BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mpathy Medical Introduces Restorelle(TM) Y


11/5/2008 6:50:09 AM

RAYNHAM, Mass.--(BUSINESS WIRE)--Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of surgical solutions used to restore pelvic health to women, is pleased to introduce its newest product - Restorelle™ Y - which is the premier solution for enhanced laparoscopic sacrocolpopexy procedures to treat pelvic organ prolapse.

“Restorelle™ Y was developed with the needs of our surgeons and patients in mind,” stated Ian Stevens, Chief Executive Officer, Mpathy Medical. “We are confident this product delivers upon our mission to offer less invasive surgical mesh solutions which yield better outcomes for patients.”

Restorelle™ Y is constructed with a unique, physiologically compatible mesh material - Smartmesh™ Technology - which was designed by surgeon specifically for the female anatomy and physiology. Utilizing an ultrasonically welded Y-shaped graft, the Restorelle™ Y procedure can be performed using an abdominal, laparoscopic, or robotic approach. The low profile of the device not only leaves less mesh behind in the patient’s body, but also enables easy passage through narrow laparoscopic ports.

“In my use of Restorelle™ Y for laparoscopic sacrocolpopexy, I have found the mesh offers enhanced surgical handling as it conforms nicely to the vaginal vault shape,” stated Dr. Charles Rardin, Women & Infants’ Hospital, Providence, RI. “The lightweight and conformability of the mesh allow for easy placement and draping during fixation. The large pores make the graft nearly transparent during laparoscopy, and enable suture passage through the mesh without needles, both of which increase the technical ease and safety of the procedure.”

Smartmesh™ Technology Benefits

* Ultra lightweight at 19 grams square meter * 71% more mature type I collagen growth than heavier meshes * New 2008 data from PFR series of 201 patients show only 1 vaginal mesh erosion in 360 mesh implants (0.28%) * 99% cure rate with no vaginal mesh erosions and no de novo dyspareunia in a PFR series of 119 patients * Two laparoscopic sacrocolpopexy series utilizing Smartmesh"" Technology indicated: o Less post-operative dyspareunia o Non-palpability o Lower vaginal tenderness and rigidity

About Mpathy Medical

Mpathy Medical is a rapidly growing medical device company which has developed and brought to market a range of surgical solutions used to restore pelvic health to women. Mpathy Medical’s core product lines - Minitape® and Restorelle™ - are used by surgeons specializing in urogynecology, gynecology, and urology to treat female urinary stress incontinence and pelvic organ prolapse. Founded in 2003 by Dr. James Browning, Mpathy Medical supplies the only surgical mesh solutions designed by a surgeon specifically for the female anatomy. The mesh - branded Smartmesh™ - is a physiologically compatible, ultra lightweight polypropylene mesh which encourages superior collagen growth and works in concert with the patient’s own natural tissue for optimum safety and results. The company is headquartered in Glasgow, Scotland with US operations in Raynham, MA and has received 510(k) clearance to market by the FDA in the US and CE marking in the UK for all its medical devices. To learn more about Mpathy Medical, visit www.mpathymedical.com.

Contact:

Mpathy Medical Karen Whelan, 866-319-8820, ext. 803 Communications Manager kwhelan@mpathymedical.com

Source: Mpathy Medical

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES